Advertisement
Screener

Genmab A/S (GMAB) Rightofuse Assets

2.8 / 5 stars · 68/120 Roast Me

Genmab A/S Rightofuse Assets

Genmab A/S (GMAB) had Rightofuse Assets of $127.00 million as of 2025-12-31, per its 20-F filed 2026-02-17.

Financial Statements › Notes

ifrs-full:RightofuseAssets · last filed 2026-02-17

  • 2024-12-31: Rightofuse Assets 913.00M DKK.
  • 2024-06-30: Rightofuse Assets 928.00M DKK.
  • 2023-12-31: Rightofuse Assets 686.00M DKK.
  • 2023-06-30: Rightofuse Assets 726.00M DKK.

DKK

Period endRightofuse AssetsRightofuse Assets as first filed
2024-12-31913.00M DKK
6-K · filed 2025-02-12
2024-06-30928.00M DKK
6-K · filed 2024-08-08
2023-12-31686.00M DKK
6-K · filed 2025-02-12
2023-06-30726.00M DKK
6-K · filed 2023-08-03
2022-12-31523.00M DKK
6-K · filed 2025-02-12
2022-06-30554.00M DKK
6-K · filed 2022-08-10
2021-12-31354.00M DKK
6-K · filed 2025-02-12
2021-06-30354.00M DKK
6-K · filed 2022-08-10
384.00M DKK
6-K · filed 2021-08-11
2020-12-31283.00M DKK
6-K · filed 2024-02-14
2020-06-30312.00M DKK
6-K · filed 2020-08-12
2019-12-31177.00M DKK
6-K · filed 2023-02-22
2019-06-30190.98M DKK
6-K · filed 2019-08-14
2019-01-01205.00M DKK
20-F · filed 2020-03-30
204.80M DKK
6-K · filed 2019-08-14

USD

Period endRightofuse Assets
2025-12-31$127.00M
20-F · filed 2026-02-17
2025-06-30$125.00M
6-K · filed 2025-08-07
2024-12-31$128.00M
20-F · filed 2026-02-17
2023-12-31$102.00M
20-F · filed 2026-02-17
2022-12-31$75.00M
20-F · filed 2026-02-17